Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 196

1.

Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways.

Luther J, Gala M, Patel SJ, Dave M, Borren N, Xavier RJ, Ananthakrishnan AN.

Dig Dis Sci. 2018 Jan 25. doi: 10.1007/s10620-018-4932-8. [Epub ahead of print]

PMID:
29372477
2.

Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women.

Burke KE, Ananthakrishnan AN, Lochhead P, Olen O, Ludvigsson JF, Richter JM, Chan AT, Khalili H.

J Crohns Colitis. 2018 Jan 23. doi: 10.1093/ecco-jcc/jjy005. [Epub ahead of print]

PMID:
29370359
3.

Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.

Schirmer M, Franzosa EA, Lloyd-Price J, McIver LJ, Schwager R, Poon TW, Ananthakrishnan AN, Andrews E, Barron G, Lake K, Prasad M, Sauk J, Stevens B, Wilson RG, Braun J, Denson LA, Kugathasan S, McGovern DPB, Vlamakis H, Xavier RJ, Huttenhower C.

Nat Microbiol. 2018 Jan 8. doi: 10.1038/s41564-017-0089-z. [Epub ahead of print]

PMID:
29311644
4.

A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients.

Hall AB, Yassour M, Sauk J, Garner A, Jiang X, Arthur T, Lagoudas GK, Vatanen T, Fornelos N, Wilson R, Bertha M, Cohen M, Garber J, Khalili H, Gevers D, Ananthakrishnan AN, Kugathasan S, Lander ES, Blainey P, Vlamakis H, Xavier RJ, Huttenhower C.

Genome Med. 2017 Nov 28;9(1):103. doi: 10.1186/s13073-017-0490-5.

5.

Difference in clinical course, genetics, and the microbiome between familial and sporadic inflammatory bowel diseases.

Borren NZ, Conway G, Garber JJ, Khalili H, Budree S, Mallick H, Yajnik V, Xavier RJ, Ananthakrishnan AN.

J Crohns Colitis. 2017 Nov 14. doi: 10.1093/ecco-jcc/jjx154. [Epub ahead of print]

PMID:
29145572
6.

"Weekend Effect" in Patients With Upper Gastrointestinal Hemorrhage: A Systematic Review and Meta-analysis.

Gupta A, Agarwal R, Ananthakrishnan AN.

Am J Gastroenterol. 2018 Jan;113(1):13-21. doi: 10.1038/ajg.2017.430. Epub 2017 Nov 14. Review.

PMID:
29134968
7.

Enabling phenotypic big data with PheNorm.

Yu S, Ma Y, Gronsbell J, Cai T, Ananthakrishnan AN, Gainer VS, Churchill SE, Szolovits P, Murphy SN, Kohane IS, Liao KP, Cai T.

J Am Med Inform Assoc. 2018 Jan 1;25(1):54-60. doi: 10.1093/jamia/ocx111.

PMID:
29126253
8.

Environmental triggers in IBD: a review of progress and evidence.

Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, Vavricka SR, Fiocchi C.

Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):39-49. doi: 10.1038/nrgastro.2017.136. Epub 2017 Oct 11. Review.

PMID:
29018271
9.

Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.

Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Lochhead P, Richter JM, Chan AT.

Inflamm Bowel Dis. 2017 Nov;23(11):1898-1904. doi: 10.1097/MIB.0000000000001236.

PMID:
28991856
10.

Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines.

Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U.

Clin Gastroenterol Hepatol. 2018 Jan;16(1):99-105. doi: 10.1016/j.cgh.2017.08.041. Epub 2017 Sep 1.

PMID:
28870657
11.

Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis.

Khalili H, de Silva PS, Ananthakrishnan AN, Lochhead P, Joshi A, Garber JJ, Richter JR, Sauk J, Chan AT.

Inflamm Bowel Dis. 2017 Jul;23(7):1088-1095. doi: 10.1097/MIB.0000000000001161.

12.

Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies.

Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN.

Clin Gastroenterol Hepatol. 2018 Feb;16(2):190-197.e11. doi: 10.1016/j.cgh.2017.05.047. Epub 2017 Jun 8.

PMID:
28603049
13.

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

Borren NZ, Conway G, Tan W, Andrews E, Garber JJ, Yajnik V, Ananthakrishnan AN.

Inflamm Bowel Dis. 2017 Jul;23(7):1234-1239. doi: 10.1097/MIB.0000000000001133.

PMID:
28520589
14.

Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases.

Ananthakrishnan AN, Luo C, Yajnik V, Khalili H, Garber JJ, Stevens BW, Cleland T, Xavier RJ.

Cell Host Microbe. 2017 May 10;21(5):603-610.e3. doi: 10.1016/j.chom.2017.04.010.

PMID:
28494241
15.

Effect of oral tobacco use and smoking on outcomes of Crohn's disease in India.

Arora U, Ananthakrishnan AN, Kedia S, Bopanna S, Mouli PV, Yadav DP, Makharia GK, Yajnik V, Ahuja V.

J Gastroenterol Hepatol. 2018 Jan;33(1):134-140. doi: 10.1111/jgh.13815.

PMID:
28475826
16.

The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact.

Borren NZ, Ghadermarzi S, Hutfless S, Ananthakrishnan AN.

PLoS One. 2017 May 2;12(5):e0176797. doi: 10.1371/journal.pone.0176797. eCollection 2017. Review.

17.

Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset.

Kochar B, Long MD, Galanko J, Raffals LE, Ananthakrishnan A, Sandler RS.

Inflamm Bowel Dis. 2017 Jul;23(7):1187-1194. doi: 10.1097/MIB.0000000000001115.

PMID:
28410340
18.

Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Bopanna S, Ananthakrishnan AN, Kedia S, Yajnik V, Ahuja V.

Lancet Gastroenterol Hepatol. 2017 Apr;2(4):269-276. doi: 10.1016/S2468-1253(17)30004-3. Epub 2017 Feb 21.

19.

Infliximab or ciclosporin for acute severe ulcerative colitis?

Ananthakrishnan AN.

Lancet Gastroenterol Hepatol. 2016 Sep;1(1):2-3. doi: 10.1016/S2468-1253(16)30016-4. Epub 2016 Jun 21. No abstract available.

20.

Modifiable Environmental Factors in Inflammatory Bowel Disease.

Burke KE, Boumitri C, Ananthakrishnan AN.

Curr Gastroenterol Rep. 2017 May;19(5):21. doi: 10.1007/s11894-017-0562-0. Review.

PMID:
28397132

Supplemental Content

Loading ...
Support Center